Obesity Pharmacotherapy 2025: Advances and Remaining Challenges
Review of obesity pharmacotherapy advancements and challenges covers GLP-1/GIP drugs, emerging agents, access barriers, and the evolving treatment landscape.
Quick Facts
What This Study Found
Review of obesity pharmacotherapy advancements and challenges covers GLP-1/GIP drugs, emerging agents, access barriers, and the evolving treatment landscape.
Key Numbers
Review covers the global increase in obesity prevalence and the expanding pharmacotherapy options available to address it.
How They Did This
Methodology in publication.
Why This Research Matters
Relevant to peptide-based therapeutic applications.
The Bigger Picture
Contributes to peptide therapeutic evidence.
What This Study Doesn't Tell Us
Limitations in publication.
Questions This Raises
- ?Long-term implications?
- ?Comparison to evidence?
- ?Next research?
Trust & Context
- Key Stat:
- Key finding Review of obesity pharmacotherapy advancements and challenges covers GLP-1/GIP drugs, emerging agent
- Evidence Grade:
- Based on study design.
- Study Age:
- Published in 2025.
- Original Title:
- Advancements and challenges in the management of obesity using pharmacotherapy (Review).
- Published In:
- Experimental and therapeutic medicine, 30(2), 162 (2025)
- Database ID:
- RPEP-09897
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Review of obesity pharmacotherapy advancements and challenges covers GLP-1/GIP drugs, emerging agents, access barriers, and the evolving treatment landscape.
How reliable?
Consult publication and provider.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09897APA
Alotaibi, Saqer S; Eldrehmy, Essam H; Albogami, Sarah M; Alkhedaide, Adel; Dahab, Omima. (2025). Advancements and challenges in the management of obesity using pharmacotherapy (Review).. Experimental and therapeutic medicine, 30(2), 162. https://doi.org/10.3892/etm.2025.12912
MLA
Alotaibi, Saqer S, et al. "Advancements and challenges in the management of obesity using pharmacotherapy (Review).." Experimental and therapeutic medicine, 2025. https://doi.org/10.3892/etm.2025.12912
RethinkPeptides
RethinkPeptides Research Database. "Advancements and challenges in the management of obesity usi..." RPEP-09897. Retrieved from https://rethinkpeptides.com/research/alotaibi-2025-advancements-and-challenges-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.